|
 
Welcome to the Shroomery Message Board! Please  login or  register to post messages and view our members-only content. You'll gain access to additional forums, encrypted messages, file attachments, board customizations, and much more!
|
 namaste
RuNnINg OwL
Registered: 12/03/02
Posts: 3,713
Loc: Fiddler's Green
Last seen: 9 hours, 58 minutes
|
 FDA: Antidepressants Pose Risk to Teens
#6347196 - 12/08/06 07:21 AM (1 year, 8 months ago) |
|
|
FDA: Antidepressants Pose Risk to Teens
By ANDREW BRIDGES 12.05.06, 5:41 PM ET
http://www.forbes.com/business/feeds/ap/2006/12/05/ap3230806.html
Using antidepressants increases the risk of suicidal thoughts and behavior among young adults but lessens it for seniors, the Food and Drug Administration said Tuesday.
The effects of antidepressants on adults from 25 to 64 were mixed, so much so that the FDA would only conclude the drug had a neutral effect on suicidal behavior for them but possibly lowers the risk of suicidal thoughts.
The information came from a mass review of 372 studies involving roughly 100,000 patients and 11 drugs, including Lexapro, Zoloft, Prozac and Paxil. The FDA analysis will be incorporated in future changes to antidepressant labels, but the agency wants to first discuss its plans with outside advisers.
In 2004, the FDA ordered strong warnings about the pediatric risk of suicidal tendencies put on antidepressant labels, and began analyzing whether adults face a similar risk, in part by requesting data from drug companies.
It now appears there is an increased risk among adults between the ages of 18 and 25.
"When results are analyzed by age, it becomes clear that there is an elevated risk for suicidality and suicidal behavior among adults younger than 25 years of age that approaches that seen in the pediatric population," the FDA said in documents that were released ahead of the Dec. 13 meeting of its psychopharmacologic drugs advisory committee.
The FDA's analysis of the multiple studies suggests an age-related shift in the risk of suicidal thoughts and behavior associated with treatment with the drugs. That means the risk appears to decline with age, even if the numbers don't explain why, the FDA said. The issue is complex to sort out because depression itself can lead to suicide.
All antidepressants now bear a so-called "black-box" warning about the increased risk of suicidal thinking and behavior in children and adolescents.
In May, GlaxoSmithKline (nyse: GSK - news - people ) and the FDA warned Paxil may raise the risk of suicidal behavior in young adults, too, and changed the drug's label to reflect that risk.
--------------------
  
Earthbeat; Heartbeat; Soul Feet
|
namaste
RuNnINg OwL
Registered: 12/03/02
Posts: 3,713
Loc: Fiddler's Green
Last seen: 9 hours, 58 minutes
|
 Re: FDA: Antidepressants Pose Risk to Teens [Re: namaste]
#6347215 - 12/08/06 07:30 AM (1 year, 8 months ago) |
|
|
I find it ridiculous that people are prescribed something that increases the amounts of neurotransmitters without ever knowing if there was even a shortage. When determining whether or not to use fertilizers, a soil test is done for N-P-K; why hasn't there been a standardized test that would measure S-N-D? My mom, a nurse, says that doctors will prescribe whatever the 'free sample in the closet is.' Not to mention that the fact that doctors conviently leave out the fact that they are habit-forming. Well, I'm just glad to see that the FDA has finally admitted there is a connection. I've tried cymbalta and cyclobenzaprine for chronic pain; they were pure evil, and made me feel completely worthless, but God Bless if they work for you 
--------------------
Earthbeat; Heartbeat; Soul Feet
|
 fastfred
Registered: 05/17/04
Posts: 4,326
Loc: Dark side of the moon
|
Re: FDA: Antidepressants Pose Risk to Teens [Re: namaste]
#6349922 - 12/09/06 01:36 AM (1 year, 8 months ago) |
|
|
Well, I suppose your suggesting then that they drill a hole in your skull, stick a syringe into your brain, then remove a sample of brain tissue or fluid for this test?
-FF
|
veggie
Registered: 07/25/04
Posts: 5,789
|
Re: FDA: Antidepressants Pose Risk to Teens [Re: fastfred]
#6349989 - 12/09/06 02:27 AM (1 year, 8 months ago) |
|
|
Quote:
fastfred said:
Well, I suppose your suggesting then that they drill a hole in your skull, stick a syringe into your brain, then remove a sample of brain tissue or fluid for this test?
This sounds a little less drastic. Very interesting if it works...
A Taste Sensitivity Test Could Determine the Appropriate Antidepressant
December 05, 2006 - Scientific American
U.K. researchers find that taste buds respond differently to depression therapies that target serotonin and noradrenaline
When faced with a depressed patient, clinicians often have to choose a proper course of treatment based on a guess as to which neurotransmitter in the brain is being disrupted--serotonin, noradrenaline or both. According to Jan Melichar, a psychiatrist at the University of Bristol, doctors "get it right about 60 to 80 percent of the time," but they have to wait up to one month to see if they chose correctly. A report appearing in the December 6 issue of The Journal of Neuroscience could result in an easier way of putting patients on a path to mental stability.
The authors, coauthored by Melichar and Lucy Donaldson, a neuroscientist and physiologist also at the University of Bristol, found that a person's sense of taste--known to be genetic and once thought to be fixed--is in fact plastic and responds to changes in neurotransmitter levels as well as to different moods. The research group gave 20 volunteers either one of two classes of common antidepressants--serotonin specific reuptake inhibitors (SSRIs) or noradrenaline reuptake inhibitors (NARIs)--or a placebo. (Each drug increases the level of its specific neurotransmitter in the brain.) Before taking the treatments and then again two hours after, the subjects took taste tests where researchers gave them solutions of tastants in different concentrations and told them what taste to expect: sour, salt, sweet or bitter. The participants then had to indicate at what concentration they could detect taste.
The team discovered that those who took SSRIs reported an increased sensitivity to sweet and bitter tastes, detecting them at concentrations of 27 percent and 53 percent lower, respectively, than before ingestion of the drug. Among those who took NARIs, they detected sour and bitter tastes at concentrations 22 percent and 39 percent lower, respectively, than before treatment. Neither group responded differently to salty tastes. Donaldson doesn't know exactly why the salt threshold remained unaffected in the short term. "It may be because there's something to do with the way that salt is detected by the taste cells within the tongue," she speculates, noting that she and Melichar believe the effects of their manipulations are taking place primarily in the taste buds and not in the brain. The team, however, did find that a decreased sensitivity to salt correlated well with higher general anxiety levels among the 20 study participants--as did sensitivity to bitterness--although no one in the study suffered from either anxiety disorders or depression.
"For a long time we thought that taste wasn't plastic," explains Linda Kennedy, a neurobiologist at Clark University in Worcester, Mass., who also studies the taste system. These findings, she continues, provide evidence that "internal stimuli will change taste sensitivity." She also notes that the connection between mood and taste sensitivity may have some applications for fighting obesity. The Bristol team, for its part, believes the work can be expanded to create a test for prescribing the right antidepressants to patients. "What we're working towards, hopefully, is to try and use taste tests and taste reactions in people as a sort of marker for the levels of those neurotransmitters in people with depression, so that we can tell if they've got a serotonin problem or a noradrenaline problem or both," Donaldson says. She admits, however, that the group still has only worked thus far with normal subjects and needs to see how tastes may be altered for people who are depressed as well as how these effects may change over the term of the illness. In addition, they would need to do both shorter- and longer-term studies to determine how these neurotransmitter manipulations play out over time. As Donaldson explains: "That will give us an idea of how much it is going on in the brain and how much of it is actually going on in the taste bud."
| |
|
|
|
Previous
Index
Next
Threaded
Edit 
Reply 
Quote 
